Back to Search
Start Over
Supplementary Table S1 from Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- List of primary GBM cell lines used in this study.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....08215a476d62975edfd68992557b059f